MarketInOut Stock Screener Log In | Sign Up

HLB Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026
HLB Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization5,304,366 mln
Float120 mln
Earnings Date08/18/2025

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.15
Reliable

Relative Strength

56 / 100
Slightly ahead

Debt / Equity

0.86
Moderate leverage

Pre-Tax Margin

-160%
Severely loss-making

ROE

-34.51
Deeply negative

Business Description

Founded in 1975 and based in Ulsan, South Korea, HLB Co. Ltd. operates across a wide range of industries. The company builds and services lifeboats and fiberglass pipes, both in South Korea and abroad. It also develops and produces medical and pharmaceutical products, including cancer treatments, biological drugs targeting infectious diseases, and everyday medical supplies such as alcohol swabs. In addition, HLB is active in e-commerce and investment activities.

Key Fundamentals

EPS-1,615
ROE-34.51
RPS738
ROIC-8.96
ROA-16.35
EBITDA, mln-124,941
EV / EBITDA-46.59
EV / EBIT-44.37
Revenue, mln97,467
EV / Revenue59.72

Quote Details

Last 40,000
Change 300 (0.76%)
Open 39,300
Volume 349,554
Turnover 13,982,159,872
Average Volume 909,866

Financial Ratios

Pre-Tax Profit Margin-160
Current Ratio0.26
Price / Book13.03
Price / Tangible Book79.40
Debt / Equity0.86
Price / Sales56.17

Financial Strength

Altman Z-Score5.87
Piotroski F-Score 3 / 9
Beneish M-Score-3.15

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.85% 35 / 100   
1 Month -0.37% 81 / 100   
2 Months 31.58% 95 / 100   
6 Months -33.22% 39 / 100   
1 Year -2.91% 62 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog